Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020
This cross-sectional study evaluates trends and factors associated with selecting active surveillance or watchful waiting among individuals with intermediate-risk prostate cancer.
Authors
- Stacy Loeb (ORCID: https://orcid.org/0000-0003-3933-9207)
- William J. Catàlona (ORCID: https://orcid.org/0009-0004-2926-5114)
- Cary P. Gross (ORCID: https://orcid.org/0000-0002-4974-935X)
- Matthew R. Cooperberg (ORCID: https://orcid.org/0000-0003-4339-6685)
- Xiaomei Ma
- Ismail Ajjawi
- Michael S. Leapman
Institutions
- Northwestern University (US)
- University of California, San Francisco (US)
- Veterans Health Administration (US)
- Yale Cancer Center (US)
- Yale University (US)
- NYU Langone Health (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1001/jama.2024.20580
- Citations
- 12
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.03